1. Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci 2017;372:307–15.
2. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1211–59.
3. Hu X, Zhou Y, Zhao H, Peng C. Migraine and the risk of stroke: an updated meta-analysis of prospective cohort studies. Neurol Sci 2017;38:33–40.
4. Sacco S, Ornello R, Ripa P, Pistoia F, Carolei A. Migraine and hemorrhagic stroke: a meta-analysis. Stroke 2013;44:3032–8.
5. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009;339:b3914.
6. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med 2010;123:612–24.
7. Sacco S, Ornello R, Ripa P, Tiseo C, Degan D, Pistoia F, et al. Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies. Eur J Neurol 2015;22:1001–11.
8. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013;12:822–38.
9. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013;12:483–97.
10. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 1987;149:351–6.
11. Wardlaw JM, Valdes Hernandez MC, Munoz-Maniega S. What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc 2015;4:001140.
12. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987;44:21–3.
13. Kwee RM, Kwee TC. Virchow-Robin spaces at MR imaging. Radiographics 2007;27:1071–86.
14. Soderlund H, Nyberg L, Adolfsson R, Nilsson LG, Launer LJ. High prevalence of white matter hyperintensities in normal aging: relation to blood pressure and cognition. Cortex 2003;39:1093–105.
15. Hopkins RO, Beck CJ, Burnett DL, Weaver LK, Victoroff J, Bigler ED. Prevalence of white matter hyperintensities in a young healthy population. J Neuroimaging 2006;16:243–51.
16. Brant-Zawadzki M, Fein G, Van Dyke C, Kiernan R, Davenport L, de Groot J. MR imaging of the aging brain: patchy white-matter lesions and dementia. AJNR Am J Neuroradiol 1985;6:675–82.
17. Zimmerman RD, Fleming CA, Lee BC, Saint-Louis LA, Deck MD. Periventricular hyperintensity as seen by magnetic resonance: prevalence and significance. AJR Am J Roentgenol 1986;146:443–50.
18. Rostrup E, Gouw AA, Vrenken H, van Straaten EC, Ropele S, Pantoni L, et al. The spatial distribution of age-related white matter changes as a function of vascular risk factors: results from the LADIS study. Neuroimage 2012;60:1597–607.
19. Griffanti L, Jenkinson M, Suri S, Zsoldos E, Mahmood A, Filippini N, et al. Classification and characterization of periventricular and deep white matter hyperintensities on MRI: a study in older adults. Neuroimage 2018;170:174–81.
20. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ, Breteler MM. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 2008;39:2712–9.
21. Seo SW, Lee JM, Im K, Park JS, Kim SH, Kim ST, et al. Cortical thinning related to periventricular and deep white matter hyperintensities. Neurobiol Aging 2012;33:1156–67.
22. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427–34.
23. Kurth T, Mohamed S, Maillard P, Zhu YC, Chabriat H, Mazoyer B, et al. Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ 2011;342:c7357.
24. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683–9.
25. Fernando MS, Simpson JE, Matthews F, Brayne C, Lewis CE, Barber R, et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury. Stroke 2006;37:1391–8.
26. Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G, et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998;44:731–9.
27. Ceroni M, Poloni TE, Tonietti S, Fabozzi D, Uggetti C, Frediani F, et al. Migraine with aura and white matter abnormalities: Notch3 mutation. Neurology 2000;54:1869–71.
28. Okeda R, Arima K, Kawai M. Arterial changes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in relation to pathogenesis of diffuse myelin loss of cerebral white matter: examination of cerebral medullary arteries by reconstruction of serial sections of an autopsy case. Stroke 2002;33:2565–9.
29. Brulin P, Godfraind C, Leteurtre E, Ruchoux MM. Morphometric analysis of ultrastructural vascular changes in CADASIL: analysis of 50 skin biopsy specimens and pathogenic implications. Acta Neuropathol 2002;104:241–8.
30. Gladstone JP, Dodick DW. Migraine and cerebral white matter lesions: when to suspect cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neurologist 2005;11:19–29.
31. Fazekas F, Koch M, Schmidt R, Offenbacher H, Payer F, Freidl W, et al. The prevalence of cerebral damage varies with migraine type: a MRI study. Headache 1992;32:287–91.
32. Igarashi H, Sakai F, Kan S, Okada J, Tazaki Y. Magnetic resonance imaging of the brain in patients with migraine. Cephalalgia 1991;11:69–74.
33. Pavese N, Canapicchi R, Nuti A, Bibbiani F, Lucetti C, Collavoli P, et al. White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia 1994;14:342–5.
34. Uggetti C, Squarza S, Longaretti F, Galli A, Di Fiore P, Reganati PF, et al. Migraine with aura and white matter lesions: an MRI study. Neurol Sci 2017;38:11–3.
35. Avci AY, Lakadamyali H, Arikan S, Benli US, Kilinc M. High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients. J Headache Pain 2015;16:9.
36. Cheng CY, Cheng HM, Chen SP, Chung CP, Lin YY, Hu HH, et al. White matter hyperintensities in migraine: clinical significance and central pulsatile hemodynamic correlates. Cephalalgia 2018;38:1225–36.
37. Lee MJ, Park BY, Cho S, Park H, Chung CS. Cerebrovascular reactivity as a determinant of deep white matter hyperintensities in migraine. Neurology 2019;92:e342. –50.
38. Eidlitz-Markus T, Zeharia A, Haimi-Cohen Y, Konen O. MRI white matter lesions in pediatric migraine. Cephalalgia 2013;33:906–13.
39. Zhang Q, Datta R, Detre JA, Cucchiara B. White matter lesion burden in migraine with aura may be associated with reduced cerebral blood flow. Cephalalgia 2017;37:517–24.
40. De Benedittis G, Lorenzetti A, Sina C, Bernasconi V. Magnetic resonance imaging in migraine and tension-type headache. Headache 1995;35:264–8.
41. Rovaris M, Bozzali M, Rocca MA, Colombo B, Filippi M. An MR study of tissue damage in the cervical cord of patients with migraine. J Neurol Sci 2001;183:43–6.
42. Cooney BS, Grossman RI, Farber RE, Goin JE, Galetta SL. Frequency of magnetic resonance imaging abnormalities in patients with migraine. Headache 1996;36:616–21.
43. Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 2004;61:1366–8.
44. Gaist D, Garde E, Blaabjerg M, Nielsen HH, Kroigard T, Ostergaard K, et al. Migraine with aura and risk of silent brain infarcts and white matter hyperintensities: an MRI study. Brain 2016;139:2015–23.
45. Monteith T, Gardener H, Rundek T, Dong C, Yoshita M, Elkind MS, et al. Migraine, white matter hyperintensities, and subclinical brain infarction in a diverse community: the northern Manhattan study. Stroke 2014;45:1830–2.
46. Palm-Meinders IH, Koppen H, Terwindt GM, Launer LJ, Konishi J, Moonen JM, et al. Structural brain changes in migraine. JAMA 2012;308:1889–97.
47. Hamedani AG, Rose KM, Peterlin BL, Mosley TH, Coker LH, Jack CR, et al. Migraine and white matter hyperintensities: the ARIC MRI study. Neurology 2013;81:1308–13.
48. Seneviratne U, Chong W, Billimoria PH. Brain white matter hyperintensities in migraine: clinical and radiological correlates. Clin Neurol Neurosurg 2013;115:1040–3.
49. Schmitz N, Admiraal-Behloul F, Arkink EB, Kruit MC, Schoonman GG, Ferrari MD, et al. Attack frequency and disease duration as indicators for brain damage in migraine. Headache 2008;48:1044–55.
50. Trauninger A, Leel-Ossy E, Kamson DO, Poto L, Aradi M, Kover F, et al. Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients. J Headache Pain 2011;12:97–103.
51. Yalcin A, Ceylan M, Bayraktutan OF, Akkurt A. Episodic migraine and white matter hyperintensities: association of pain lateralization. Pain Med 2018;19:2051–7.
52. Adami A, Rossato G, Cerini R, Thijs VN, Pozzi-Mucelli R, Anzola GP, et al. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients. Neurology 2008;71:101–7.
53. Del Sette M, Dinia L, Bonzano L, Roccatagliata L, Finocchi C, Parodi RC, et al. White matter lesions in migraine and right-to-left shunt: a conventional and diffusion MRI study. Cephalalgia 2008;28:376–82.
54. Jiang XH, Wang SB, Tian Q, Zhong C, Zhang GL, Li YJ, et al. Right-to-left shunt and subclinical ischemic brain lesions in Chinese migraineurs: a multicentre MRI study. BMC Neurol 2018;18:18.
55. Koppen H, Palm-Meinders IH, Mess WH, Keunen RW, Terwindt GM, Launer LJ, et al. Systemic right-to-left shunts, ischemic brain lesions, and persistent migraine activity. Neurology 2016;86:1668–75.
56. Yoon GJ, Kim JT, Chang J, Kim DE, Cho BH, Lee JH, et al. Right-to-left shunts as a cause of juxtacortical spots in patients with migraine. Eur J Neurol 2012;19:1086–92.
57. Park HK, Lee SY, Kim SE, Yun CH, Kim SH. Small deep white matter lesions are associated with right-to-left shunts in migraineurs. J Neurol 2011;258:427–33.
58. Iwasaki A, Suzuki K, Takekawa H, Takashima R, Suzuki A, Suzuki S, et al. The relationship between right-to-left shunt and brain white matter lesions in Japanese patients with migraine: a single center study. J Headache Pain 2017;18:3.
59. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666.
60. Wen K, Nguyen NT, Hofman A, Ikram MA, Franco OH. Migraine is associated with better cognition in the middle-aged and elderly: the Rotterdam Study. Eur J Neurol 2016;23:1510–6.
61. Baars MA, van Boxtel MP, Jolles J. Migraine does not affect cognitive decline: results from the Maastricht aging study. Headache 2010;50:176–84.
62. Rist PM, Kang JH, Buring JE, Glymour MM, Grodstein F, Kurth T. Migraine and cognitive decline among women: prospective cohort study. BMJ 2012;345:e5027.
63. Xie H, Zhang Q, Huo K, Liu R, Jian ZJ, Bian YT, et al. Association of white matter hyperintensities with migraine features and prognosis. BMC Neurol 2018;18:93.
64. Park BY, Lee MJ, Lee SH, Cha J, Chung CS, Kim ST, et al. DEWS (DEep White matter hyperintensity Segmentation framework): a fully automated pipeline for detecting small deep white matter hyperintensities in migraineurs. Neuroimage Clin 2018;18:638–47.
65. Hong J, Park BY, Lee MJ, Chung CS, Cha J, Park H. Twostep deep neural network for segmentation of deep white matter hyperintensities in migraineurs. Comput Methods Programs Biomed 2020;183:105065.
66. Sam K, Peltenburg B, Conklin J, Sobczyk O, Poublanc J, Crawley AP, et al. Cerebrovascular reactivity and white matter integrity. Neurology 2016;87:2333–9.
67. Tuladhar AM, van Norden AG, de Laat KF, Zwiers MP, van Dijk EJ, Norris DG, et al. White matter integrity in small vessel disease is related to cognition. Neuroimage Clin 2015;7:518–24.
68. Fazekas F, Ropele S, Enzinger C, Gorani F, Seewann A, Petrovic K, et al. MTI of white matter hyperintensities. Brain 2005;128:2926–32.
69. Arkink EB, Palm-Meinders IH, Koppen H, Milles J, van Lew B, Launer LJ, et al. Microstructural white matter changes preceding white matter hyperintensities in migraine. Neurology 2019;93:e688. –94.
70. Heye AK, Culling RD, Valdes Hernandez Mdel C, Thrippleton MJ, Wardlaw JM. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI: a systematic review. Neuroimage Clin 2014;6:262–74.
71. Hougaard A, Amin FM, Christensen CE, Younis S, Wolfram F, Cramer SP, et al. Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura. Brain 2017;140:1633–42.
72. Amin FM, Hougaard A, Cramer SP, Christensen CE, Wolfram F, Larsson HBW, et al. Intact blood-brain barrier during spontaneous attacks of migraine without aura: a 3T DCE-MRI study. Eur J Neurol 2017;24:1116–24.
73. Kim YS, Kim M, Choi SH, You SH, Yoo RE, Kang KM, et al. Altered vascular permeability in migraine-associated brain regions: evaluation with dynamic contrast-enhanced MRI. Radiology 2019;292:713–20.